The Medicines Debate in De Balie

How can we keep medicines accessible and affordable for everyone in the Netherlands and the rest of the world? Now that the Netherlands has made a remarkably slow start with its Covid-19 vaccination campaign, the topic of access to medicines is again high on the (political) agenda. So how can we improve this access to medicines? Several candidate MPs will discuss this during The Medicines Debate (‘Het Geneesmiddelendebat’ in Dutch) on February 25th, 20:00 at the venue De Balie, which will be broadcast online.

Watch ‘Het Geneesmiddelendebat’ (The Medicines Debate)
– February 25th at 20:00
– (Free) livestream on the website of De Balie via https://debalie.nl/programma/de-verkiezingen-het-grote-geneesmiddelendebat-25-02-2021/

Read more (in Dutch).

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News items

Launch EU Health Workforce Projects Cluster: how can we manage medical deserts?

15-09-2021

During the webinar ‘How to effectively manage medical deserts, task shifting and retention policies?’ on September 20th, the EU Health Policy Forum will officially launch its Health Workforce Projects Cluster. One of the five projects within this cluster is the Wemos-led project Action for Health and Equity: Addressing medical Deserts (AHEAD). At the webinar, Corinne Hinlopen (Wemos) will introduce AHEAD and explain how the project partners want to address health worker shortages in isolated or depopulated areas, known as ‘medical deserts’.

Continue reading

Research shows Moderna’s triple jackpot: subsidies, high prices and tax avoidance

13-07-2021

Research by SOMO in cooperation with Wemos reveals that Covid-19 vaccine manufacturer Moderna avoids taxes on the profits it generates with billions of public funding. First the pharmaceutical company receives government subsidies for the development of its vaccine, then it sells the vaccines to governments for high prices, and in the end it transfers the majority of the profits to tax havens. Wemos and SOMO urge governments to attach conditions to public investments in development of vaccines and medicines, to ensure the accessibility and affordability of these products.

Continue reading